M. Fujinaga

2.3k total citations
18 papers, 1.9k citations indexed

About

M. Fujinaga is a scholar working on Molecular Biology, Materials Chemistry and Pharmacology. According to data from OpenAlex, M. Fujinaga has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Materials Chemistry and 3 papers in Pharmacology. Recurrent topics in M. Fujinaga's work include Enzyme Structure and Function (10 papers), Protein Structure and Dynamics (7 papers) and Biochemical and Structural Characterization (4 papers). M. Fujinaga is often cited by papers focused on Enzyme Structure and Function (10 papers), Protein Structure and Dynamics (7 papers) and Biochemical and Structural Characterization (4 papers). M. Fujinaga collaborates with scholars based in Canada, United States and Netherlands. M. Fujinaga's co-authors include Michael N.G. James, Randy J. Read, Anita R. Sielecki, M.M. Cherney, M.E. Fraser, Maia M. Chernaia, M. Laskowski, Wojciech Ardelt, Gary D. Brayer and Louis T. J. Delbaere and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M. Fujinaga

18 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Fujinaga Canada 16 1.3k 511 291 232 187 18 1.9k
Michael N.G. James Canada 22 1.3k 1.0× 426 0.8× 302 1.0× 320 1.4× 225 1.2× 32 2.3k
Anita R. Sielecki Canada 20 2.1k 1.6× 812 1.6× 489 1.7× 378 1.6× 66 0.4× 24 2.9k
Anne‐Marie Gilles France 29 1.9k 1.5× 676 1.3× 147 0.5× 251 1.1× 113 0.6× 81 2.6k
Klaus Fütterer United Kingdom 27 1.5k 1.1× 321 0.6× 298 1.0× 185 0.8× 200 1.1× 55 2.6k
M. Cymborowski United States 17 2.1k 1.6× 663 1.3× 103 0.4× 224 1.0× 79 0.4× 38 2.9k
Sherin S. Abdel‐Meguid United States 27 1.2k 1.0× 220 0.4× 73 0.3× 302 1.3× 133 0.7× 52 2.5k
W. A. Paciorek Switzerland 14 1.8k 1.4× 736 1.4× 84 0.3× 247 1.1× 61 0.3× 28 2.7k
David E. Anderson United States 23 2.5k 1.9× 729 1.4× 141 0.5× 221 1.0× 138 0.7× 43 3.4k
Patrick L. Wintrode United States 28 2.0k 1.5× 636 1.2× 250 0.9× 120 0.5× 46 0.2× 67 2.7k
Jay Painter United States 5 1.4k 1.1× 501 1.0× 112 0.4× 135 0.6× 84 0.4× 9 1.9k

Countries citing papers authored by M. Fujinaga

Since Specialization
Citations

This map shows the geographic impact of M. Fujinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Fujinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Fujinaga more than expected).

Fields of papers citing papers by M. Fujinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Fujinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Fujinaga. The network helps show where M. Fujinaga may publish in the future.

Co-authorship network of co-authors of M. Fujinaga

This figure shows the co-authorship network connecting the top 25 collaborators of M. Fujinaga. A scholar is included among the top collaborators of M. Fujinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Fujinaga. M. Fujinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fraser, M.E., M. Fujinaga, M.M. Cherney, et al.. (2004). Structure of Shiga Toxin Type 2 (Stx2) from Escherichia coli O157:H7. Journal of Biological Chemistry. 279(26). 27511–27517. 224 indexed citations
2.
Fujinaga, M., M.M. Cherney, Hiroshi Ōyama, Kōhei Oda, & Michael N.G. James. (2004). The molecular structure and catalytic mechanism of a novel carboxyl peptidase from Scytalidium lignicolum. Proceedings of the National Academy of Sciences. 101(10). 3364–3369. 73 indexed citations
3.
Fujinaga, M., M.M. Cherney, Nadya I. Tarasova, et al.. (2000). Structural study of the complex between human pepsin and a phosphorus-containing peptidic transition-state analog. Acta Crystallographica Section D Biological Crystallography. 56(3). 272–279. 17 indexed citations
4.
Fujinaga, M., Kui Huang, Katherine Bateman, & Michael N.G. James. (1998). Computational analysis of the binding of P1 variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B 1 1Edited by B. Honig. Journal of Molecular Biology. 284(5). 1683–1694. 7 indexed citations
5.
Fujinaga, M., et al.. (1996). The Crystal Structure of PR3, a Neutrophil Serine Proteinase Antigen of Wegener's Granulomatosis Antibodies. Journal of Molecular Biology. 261(2). 267–278. 129 indexed citations
6.
Fujinaga, M., et al.. (1995). Crystal structure of human pepsin and its complex with pepstatin. Protein Science. 4(5). 960–972. 114 indexed citations
7.
Fujinaga, M., C. Berthet-Colominas, A. Yaremchuk, M. A. Tukalo, & S. Cusack. (1993). Refined Crystal Structure of the Seryl-tRNA Synthetase from Thermus thermophilus at 2·5 Å Resolution. Journal of Molecular Biology. 234(1). 222–233. 90 indexed citations
8.
Sielecki, Anita R., M. Fujinaga, Randy J. Read, & Michael N.G. James. (1991). Refined structure of porcine pepsinogen at 1·8 Å resolution. Journal of Molecular Biology. 219(4). 671–692. 83 indexed citations
9.
Gros, Piet, M. Fujinaga, B.W. Dijkstra, K.H. Kalk, & Wim G. J. Hol. (1989). Crystallographic refinement by incorporation of molecular dynamics: thermostable serine protease thermitase complexed with eglin c. Acta Crystallographica Section B Structural Science. 45(5). 488–499. 41 indexed citations
10.
Hayakawa, Koto, M. Fujinaga, M.E.P. Murphy, et al.. (1989). Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 Å Resolution. Science. 243(4896). 1346–1351. 166 indexed citations
11.
Fujinaga, M., Piet Gros, & W. F. van Gunsteren. (1989). Testing the method of crystallographic refinement using molecular dynamics. Journal of Applied Crystallography. 22(1). 1–8. 61 indexed citations
12.
Fujinaga, M. & Michael N.G. James. (1987). Rat submaxillary gland serine protease, tonin. Journal of Molecular Biology. 195(2). 373–396. 108 indexed citations
13.
Fujinaga, M., Anita R. Sielecki, Randy J. Read, et al.. (1987). Crystal and molecular structures of the complex of α-chymotrypsin with its inhibitor Turkey ovomucoid third domain at 1.8 Å resolution. Journal of Molecular Biology. 195(2). 397–418. 192 indexed citations
14.
Fujinaga, M. & Randy J. Read. (1987). Experiences with a new translation-function program. Journal of Applied Crystallography. 20(6). 517–521. 159 indexed citations
15.
Fujinaga, M., Louis T. J. Delbaere, Gary D. Brayer, & Michael N.G. James. (1985). Refined structure of α-lytic protease at 1.7 Å resolution analysis of hydrogen bonding and solvent structure. Journal of Molecular Biology. 184(3). 479–502. 158 indexed citations
16.
Read, Randy J., et al.. (1984). Conformational flexibility in the third domain of the turkey ovomucoid inhibitor bound to SGPB and α-chymotrypsin. Acta Crystallographica Section A Foundations of Crystallography. 40(a1). C50–C51. 3 indexed citations
17.
Read, Randy J., M. Fujinaga, Anita R. Sielecki, & Michael N.G. James. (1983). Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-.ANG. resolution. Biochemistry. 22(19). 4420–4433. 171 indexed citations
18.
Fujinaga, M., Randy J. Read, Anita R. Sielecki, et al.. (1982). Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey.. Proceedings of the National Academy of Sciences. 79(16). 4868–4872. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael N.G. James Breakdown of academic impact, for papers by Anita R. Sielecki Breakdown of academic impact, for papers by Anne‐Marie Gilles Breakdown of academic impact, for papers by Klaus Fütterer Breakdown of academic impact, for papers by M. Cymborowski Breakdown of academic impact, for papers by Sherin S. Abdel‐Meguid Breakdown of academic impact, for papers by W. A. Paciorek Breakdown of academic impact, for papers by David E. Anderson Breakdown of academic impact, for papers by Patrick L. Wintrode Breakdown of academic impact, for papers by Jay Painter
Rankless by CCL
2026